GT BIOPHARMA, INC. Operating Cash Flow
GT BIOPHARMA, INC. (GTBP) reported Operating Cash Flow of -$6.73 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-14
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$4.26M.
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$2.47M.
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$4.02M.
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$3.68M.
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2025 was -$12.91M.
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2024 was -$12.90M.
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2023 was -$8.85M.
- GT BIOPHARMA, INC. net cash provided by (used in) operating activities for fiscal 2022 was -$15.22M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$4.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$6.73M 10-Q · filed 2026-08-14 | -$10.75M derived: sum of 3 quarters · filed 2026-08-14 | -$14.43M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$2.47M 10-Q · filed 2026-05-15 | -$6.49M derived: sum of 2 quarters · filed 2026-05-15 | -$10.17M derived: sum of 3 quarters · filed 2026-05-15 | -$13.18M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$4.02M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | -$7.70M derived: sum of 2 quarters · filed 2026-03-06 | -$10.71M derived: sum of 3 quarters · filed 2026-08-14 | -$12.91M 10-K · filed 2026-03-02 |
| 2025-09-30 | -$3.68M derived: 10-Q/A 9 month − 10-Q 6 month · filed 2026-03-06 | -$6.69M derived: sum of 2 quarters · filed 2026-08-14 | -$8.89M 10-Q/A · filed 2026-03-06 | -$11.36M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$5.22M 10-Q · filed 2026-08-14 | -$7.68M derived: sum of 3 quarters · filed 2026-08-14 | -$10.42M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$2.20M 10-Q · filed 2026-05-15 | -$4.67M derived: sum of 2 quarters · filed 2026-05-15 | -$7.41M derived: sum of 3 quarters · filed 2026-05-15 | -$10.94M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$2.47M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | -$5.21M derived: sum of 2 quarters · filed 2026-03-06 | -$8.74M derived: sum of 3 quarters · filed 2026-03-06 | -$12.90M 10-K · filed 2026-03-02 |
| 2024-09-30 | -$2.74M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2026-03-06 | -$6.27M derived: sum of 2 quarters · filed 2026-03-06 | -$10.44M 10-Q/A · filed 2026-03-06 | -$12.48M derived: sum of 4 quarters · filed 2026-03-06 |
| 2024-06-30 | -$3.54M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-03-06 | -$7.70M 10-Q/A · filed 2026-03-06 | -$9.75M derived: sum of 3 quarters · filed 2026-03-06 | -$11.71M derived: sum of 4 quarters · filed 2026-03-06 |
| 2024-03-31 | -$4.16M 10-Q · filed 2025-05-15 | -$6.21M derived: sum of 2 quarters · filed 2025-05-15 | -$8.17M derived: sum of 3 quarters · filed 2025-05-15 | -$10.11M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | -$2.05M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$4.01M derived: sum of 2 quarters · filed 2025-02-21 | -$5.95M derived: sum of 3 quarters · filed 2025-02-21 | -$8.85M 10-K · filed 2025-02-21 |
| 2023-09-30 | -$1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$3.90M derived: sum of 2 quarters · filed 2024-11-14 | -$6.80M 10-Q · filed 2024-11-14 | -$11.10M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | -$4.84M 10-Q · filed 2024-08-14 | -$9.14M derived: sum of 3 quarters · filed 2024-08-14 | -$12.06M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | -$2.91M 10-Q · filed 2024-05-15 | -$7.20M derived: sum of 2 quarters · filed 2024-05-15 | -$10.12M derived: sum of 3 quarters · filed 2024-05-15 | -$12.91M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | -$4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | -$7.22M derived: sum of 2 quarters · filed 2024-03-26 | -$10.00M derived: sum of 3 quarters · filed 2024-03-26 | -$15.22M 10-K · filed 2024-03-26 |
| 2022-09-30 | -$2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$5.70M derived: sum of 2 quarters · filed 2023-11-01 | -$10.92M 10-Q · filed 2023-11-01 | -$14.62M derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | -$2.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$8.00M 10-Q · filed 2023-08-07 | -$11.71M derived: sum of 3 quarters · filed 2023-08-07 | -$15.63M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$5.21M 10-Q · filed 2023-05-15 | -$8.92M derived: sum of 2 quarters · filed 2023-05-15 | -$12.85M derived: sum of 3 quarters · filed 2023-05-15 | -$17.14M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | -$3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$7.63M derived: sum of 2 quarters · filed 2023-03-30 | -$11.92M derived: sum of 3 quarters · filed 2023-03-30 | -$15.61M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$3.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-31 | -$8.22M derived: sum of 2 quarters · filed 2022-10-31 | -$11.90M 10-Q · filed 2022-10-31 | -$13.83M derived: sum of 4 quarters · filed 2022-10-31 |
| 2021-06-30 | -$4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$7.97M 10-Q · filed 2022-08-15 | -$9.90M derived: sum of 3 quarters · filed 2022-08-15 | -$11.60M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | -$3.68M 10-Q · filed 2022-05-16 | -$5.61M derived: sum of 2 quarters · filed 2022-05-16 | -$7.31M derived: sum of 3 quarters · filed 2022-05-16 | -$10.72M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$1.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$3.63M derived: sum of 2 quarters · filed 2022-03-28 | -$7.04M derived: sum of 3 quarters · filed 2022-03-28 | -$7.26M 10-K · filed 2022-03-28 |
| 2020-09-30 | -$1.70M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-10 | -$5.11M derived: sum of 2 quarters · filed 2021-12-29 | -$5.33M 10-Q · filed 2021-11-10 | -$5.82M derived: sum of 4 quarters · filed 2021-12-29 |
| 2020-06-30 | -$3.41M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2021-12-29 | -$3.63M 10-Q/A · filed 2021-12-29 | -$4.12M derived: sum of 3 quarters · filed 2021-12-29 | -$5.25M derived: sum of 4 quarters · filed 2021-12-29 |
| 2020-03-31 | -$223.00K 10-Q · filed 2021-05-17 | -$708.00K derived: sum of 2 quarters · filed 2021-05-17 | -$1.83M derived: sum of 3 quarters · filed 2021-05-17 | -$2.92M derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | -$485.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | -$1.61M derived: sum of 2 quarters · filed 2021-04-16 | -$2.70M derived: sum of 3 quarters · filed 2021-04-16 | -$3.66M 10-K · filed 2021-04-16 |
| 2019-09-30 | -$1.13M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-13 | -$2.21M derived: sum of 2 quarters · filed 2020-11-13 | -$3.17M 10-Q · filed 2020-11-13 | -$4.42M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | -$1.09M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-18 | -$2.05M 10-Q/A · filed 2020-08-18 | -$3.29M derived: sum of 3 quarters · filed 2020-08-18 | -$6.72M derived: sum of 4 quarters · filed 2020-08-18 |
| 2019-03-31 | -$961.00K 10-Q · filed 2020-05-15 | -$2.21M derived: sum of 2 quarters · filed 2020-05-15 | -$5.64M derived: sum of 3 quarters · filed 2020-05-15 | -$7.41M derived: sum of 4 quarters · filed 2020-05-15 |
| 2018-12-31 | -$1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$4.68M derived: sum of 2 quarters · filed 2020-03-27 | -$6.45M derived: sum of 3 quarters · filed 2020-03-27 | -$10.68M 10-K · filed 2020-03-27 |
| 2018-09-30 | -$3.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$5.21M derived: sum of 2 quarters · filed 2019-11-14 | -$9.43M 10-Q · filed 2019-11-14 | -$11.59M derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | -$6.00M 10-Q · filed 2019-08-14 | -$8.15M derived: sum of 3 quarters · filed 2019-08-14 | -$10.39M derived: sum of 4 quarters · filed 2019-08-14 |
| 2018-03-31 | -$4.23M 10-Q · filed 2019-05-15 | -$6.38M derived: sum of 2 quarters · filed 2019-05-15 | -$8.62M derived: sum of 3 quarters · filed 2019-05-15 | -$9.01M derived: sum of 4 quarters · filed 2019-05-15 |
| 2017-12-31 | -$2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$4.39M derived: sum of 2 quarters · filed 2019-03-29 | -$4.78M derived: sum of 3 quarters · filed 2019-03-29 | -$5.43M 10-K · filed 2019-03-29 |
| 2017-09-30 | -$2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$2.63M derived: sum of 2 quarters · filed 2018-11-14 | -$3.28M 10-Q · filed 2018-11-14 | -$3.41M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$391.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$1.04M 10-Q · filed 2018-08-14 | -$1.18M derived: sum of 3 quarters · filed 2018-08-14 | -$1.74M derived: sum of 4 quarters · filed 2018-08-14 |
| 2017-03-31 | -$650.00K 10-Q · filed 2018-05-15 | -$785.00K derived: sum of 2 quarters · filed 2018-05-15 | -$1.35M derived: sum of 3 quarters · filed 2018-05-15 | -$2.41M derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$135.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | -$698.00K derived: sum of 2 quarters · filed 2018-03-01 | -$1.76M derived: sum of 3 quarters · filed 2018-03-01 | -$1.93M 10-K · filed 2018-03-01 |
| 2016-09-30 | -$563.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | -$1.63M derived: sum of 2 quarters · filed 2018-02-28 | -$1.79M 10-Q/A · filed 2018-02-28 | -$2.74M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-06-30 | -$1.06M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | -$1.23M 10-Q/A · filed 2018-02-28 | -$2.18M derived: sum of 3 quarters · filed 2018-02-28 | -$2.81M derived: sum of 4 quarters · filed 2018-02-28 |
| 2016-03-31 | -$167.00K 10-Q/A · filed 2018-02-28 | -$1.11M derived: sum of 2 quarters · filed 2018-02-28 | -$1.74M derived: sum of 3 quarters · filed 2018-02-28 | -$3.04M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-12-31 | -$944.00K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | -$1.58M derived: sum of 2 quarters · filed 2018-02-28 | -$2.87M derived: sum of 3 quarters · filed 2018-02-28 | -$4.66M 10-K/A · filed 2018-02-28 |
| 2015-09-30 | -$633.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | -$1.93M derived: sum of 2 quarters · filed 2018-02-28 | -$3.71M 10-Q/A · filed 2018-02-28 | -$4.75M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-06-30 | -$1.29M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | -$3.08M 10-Q/A · filed 2018-02-28 | -$4.12M derived: sum of 3 quarters · filed 2018-02-28 | -$4.70M derived: sum of 4 quarters · filed 2018-02-28 |
| 2015-03-31 | -$1.79M 10-Q/A · filed 2018-02-28 | -$2.83M derived: sum of 2 quarters · filed 2018-02-28 | -$3.40M derived: sum of 3 quarters · filed 2018-02-28 | -$3.45M derived: sum of 4 quarters · filed 2018-02-28 |
| 2014-12-31 | -$1.04M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | -$1.62M derived: sum of 2 quarters · filed 2018-02-28 | -$1.66M derived: sum of 3 quarters · filed 2018-02-28 | -$1.75M 10-K/A · filed 2018-02-28 |
| 2014-09-30 | -$578.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | -$621.00K derived: sum of 2 quarters · filed 2015-11-13 | -$711.00K 10-Q · filed 2015-11-13 | -$1.08M derived: sum of 4 quarters · filed 2015-11-13 |
| 2014-06-30 | -$43.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$133.00K 10-Q · filed 2015-08-14 | -$502.00K derived: sum of 3 quarters · filed 2015-08-14 | -$457.00K derived: sum of 4 quarters · filed 2015-08-14 |
| 2014-03-31 | -$90.00K 10-Q · filed 2015-05-14 | -$459.00K derived: sum of 2 quarters · filed 2015-05-14 | -$414.00K derived: sum of 3 quarters · filed 2015-05-14 | -$394.00K derived: sum of 4 quarters · filed 2015-05-14 |
| 2013-12-31 | -$369.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$324.00K derived: sum of 2 quarters · filed 2015-03-31 | -$304.00K derived: sum of 3 quarters · filed 2015-03-31 | -$442.00K 10-K · filed 2015-03-31 |
| 2013-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-01-08 | $65.00K derived: sum of 2 quarters · filed 2015-01-08 | -$73.00K 10-Q · filed 2015-01-08 | -$287.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2013-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-08 | -$118.00K 10-Q · filed 2015-01-08 | -$332.00K derived: sum of 3 quarters · filed 2015-01-08 | -$610.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2013-03-31 | -$138.00K 10-Q · filed 2015-01-08 | -$352.00K derived: sum of 2 quarters · filed 2015-01-08 | -$630.00K derived: sum of 3 quarters · filed 2015-01-08 | -$933.00K derived: sum of 4 quarters · filed 2015-01-08 |
| 2012-12-31 | -$214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | -$492.00K derived: sum of 2 quarters · filed 2015-01-08 | -$795.00K derived: sum of 3 quarters · filed 2015-01-08 | -$987.00K 10-K · filed 2015-01-08 |
| 2012-09-30 | -$278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-12-17 | -$581.00K derived: sum of 2 quarters · filed 2014-12-17 | -$773.00K 10-Q · filed 2014-12-17 | -$1.10M derived: sum of 4 quarters · filed 2014-12-17 |
| 2012-06-30 | -$303.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-12 | -$495.00K 10-Q · filed 2014-12-12 | -$819.00K derived: sum of 3 quarters · filed 2014-12-12 | -$918.00K derived: sum of 4 quarters · filed 2014-12-12 |
| 2012-03-31 | -$192.00K 10-Q · filed 2014-12-10 | -$516.00K derived: sum of 2 quarters · filed 2014-12-10 | -$615.00K derived: sum of 3 quarters · filed 2014-12-10 | -$1.01M derived: sum of 4 quarters · filed 2014-12-10 |
| 2011-12-31 | -$324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | -$423.00K derived: sum of 2 quarters · filed 2014-11-18 | -$816.00K derived: sum of 3 quarters · filed 2014-11-18 | -$963.00K 10-K · filed 2014-11-18 |
| 2011-09-30 | -$99.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-21 | -$492.00K derived: sum of 2 quarters · filed 2012-11-21 | -$639.00K 10-Q · filed 2012-11-21 | -$1.02M derived: sum of 4 quarters · filed 2012-11-21 |
| 2011-06-30 | -$393.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | -$540.00K 10-Q/A · filed 2012-09-13 | -$917.00K derived: sum of 3 quarters · filed 2012-09-13 | -$1.31M derived: sum of 4 quarters · filed 2012-09-13 |
| 2011-03-31 | -$147.00K 10-Q · filed 2012-05-21 | -$524.00K derived: sum of 2 quarters · filed 2012-05-21 | -$914.00K derived: sum of 3 quarters · filed 2012-05-21 | |
| 2010-12-31 | -$377.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$767.00K derived: sum of 2 quarters · filed 2012-04-16 | -$1.53M 10-K · filed 2012-04-16 | |
| 2010-09-30 | -$390.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | -$1.16M 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | -$768.00K 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |